Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Nicolas Gikakis forfeited 1,786 shares of common stock to cover tax withholdings related to vested restricted stock units.

Summary

• Nicolas Gikakis, a Director of Aethlon Medical Inc. (AEMD), reported a change in beneficial ownership.
• On September 30, 2025, Gikakis forfeited 1,786 shares of common stock.
• This forfeiture was executed to cover tax withholdings associated with the conversion of 4,465 vested and outstanding restricted stock units (RSUs) into common stock.
• The market price used for the forfeiture was $0.749 per share.
• Following this transaction, Gikakis beneficially owns 22,683 shares of common stock directly.
• The original RSU grant was previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: The transaction represents a routine forfeiture of shares by a director to satisfy tax obligations upon the vesting of restricted stock units, which is a standard compensation practice and does not reflect a change in company performance or outlook.

Negatives

• A slight reduction in the director's direct beneficial ownership of 1,786 shares, although for a routine tax purpose.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This transaction is a routine insider filing related to equity compensation and tax obligations, which is a common occurrence across all publicly traded companies and does not reflect specific industry trends or competitive dynamics.

Comparison to Industry Standards

• The forfeiture of shares to cover tax withholdings upon the vesting and conversion of restricted stock units is a standard and widely accepted practice in executive compensation across various industries, including biotechnology and medical devices, aligning with typical equity compensation plans.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine tax-related transaction and the director continues to hold a significant number of shares, indicating continued alignment of interests.
• Management: Standard compliance with equity compensation and tax regulations for the director.

Key Dates

Recommendation

This Form 4 reports a routine forfeiture of shares by a director to cover tax withholdings upon RSU vesting, which is a common practice and does not indicate a change in the company's fundamental outlook or warrant a change in investment recommendation. The transaction is a standard administrative event related to executive compensation.

Keywords

AEMD, Aethlon Medical, Form 4, Insider Transaction, Stock Forfeiture, Director, Equity Compensation, Restricted Stock Units, Tax Withholding